UNSPSC 51102862: Oxytetracycline/polymyxin b

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE109. This VA Drug Class (DE109) classifies this compound as belonging to the group ANTI-INFECTIVE, TOPICAL, OTHER.

UNSPSC 51102862 Oxytetracycline/polymyxin b is a Commodity code that encompasses pharmaceutical products and related medical supplies procured by state and local health departments, county health systems, and public health agencies. Recent state and local solicitations under this code show activity in pharmaceutical warehouse ordering and emergency medical supply procurement, including antibiotics and naloxone-based products for community health support and emergency response initiatives. Issuing bodies include state departments of public health and county health authorities managing inventory for clinical use and public health programs.

Activity under the code concentrates in Illinois and Florida, with the Illinois Department of Public Health awarding a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 (Solicitation 26482DPHPREPDB53392, a completed IFB award valued at $2,999,999.11 over three years for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets), and Seminole County, Florida issuing an IFB (60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. Cooperative purchasing vehicles such as MMCAP Infuse are in use to aggregate demand across jurisdictions and reduce acquisition costs through piggyback contracting.